Cancer Center have created a tool that uses machine learning to assess a non-Hodgkin lymphoma (NHL) patient's likely response ...

Experts discuss how the 5-year outcomes of polatuzumab have influenced its position in current NCCN guidelines for diffuse ...

June 20, 2024 — Research scientists found that a 'one-two punch' of combining the immunosuppressive drug ruxolitinib with existing checkpoint inhibitor therapies may be a more effective way to ...

The bill that would limit "failure to warn" lawsuits against pesticide makers now faces House consideration and must survive ...

A new article outlines a new tool that measures blood inflammation as a marker for poor CAR T therapy outcomes.

Researchers from the City of Hope and Memorial Sloan Kettering (MSK) Cancer Center, US, have developed a tool named ...

A rep for the 65-year-old 'Full House' actor confirmed that he was cancer-free after a stage 3 non-Hodgkin Lymphoma diagnosis last year Charlotte Phillipp is a Weekend Writer-Reporter at PEOPLE.

Experts discuss the 5-year efficacy and safety outcomes of polatuzumab in diffuse large B-cell lymphoma (DLBCL), highlighting ...

Lymphoma is a type of cancer that begins in immune system cells, called lymphocytes. It generally presents as a solid tumor of lymphoid cells and can develop in the lymph nodes, spleen, bone ...

Researchers from City of Hope develop test using machine learning to predict immunotherapy response in lymphoma patients: Los Angeles Wednesday, April 2, 2025, 12:00 Hrs [IST] Res ...

As part of NAD’s probe into the Skims posts, they asked Del Rey to modify all three posts to include #ad or #sponsored, per ...

Researchers with City of Hope, one of the largest and most advanced cancer research and treatment organizations in the United States ...